GlassScriptPhysician profile
D'Anne Moon
NPI 1083659395
$1,112.13
in general payments reported to CMS, 2019-2025
21 companies · $82.51 in 2025
The $82.51 reported for 2025 was more than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $291 · 2022: $290 · 2023: $283 · 2024: $166 · 2025: $82.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.54 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $261.83 | 2021-2025 | |
| Astellas Pharma US INC | $149.72 | 2021-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $101.68 | 2021-2025 | Myosure Tissue Removal Device, Novasure |
| Evofem Biosciences, INC. | $98.93 | 2021-2022 | |
| Organon LLC | $90.60 | 2021-2024 | Nexplanon |
| Ascend Therapeutics US, LLC | $71.65 | 2022-2023 | |
| Biogen, INC. | $62.34 | 2024-2025 | Zurzuvae |
| Becton, Dickinson and Company | $60.80 | 2022-2024 | Bd Onclarity |
| Aspira Women'S Health INC | $32.77 | 2021 | |
| Medicem INC. | $19.54 | 2022 | |
| Roche Diagnostics Corporation | $18.06 | 2021 | |
| Intuitive Surgical, INC. | $17.50 | 2024 | |
| Pfizer INC. | $16.95 | 2024 | |
| Acella Pharmaceuticals, LLC | $15.28 | 2024 | NP Thyroid 60 |
| Urovant Sciences INC | $14.88 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $14.79 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $14.38 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $13.17 | 2024 | Bd Onclarity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.49 | 2021 | |
| Coopersurgical, INC. | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw D'Anne Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.